Transmedics Group Inc’s filing revealed that its President & CEO Hassanein Waleed H unloaded Company’s shares for reported $1.51 million on May 02 ’24. In the deal valued at $121.41 per share,12,444 shares were sold. As a result of this transaction, Hassanein Waleed H now holds 61,643 shares worth roughly $7.89 million.
Then, Khayal Tamer I sold 63,260 shares, generating $6,866,360 in total proceeds. Upon selling the shares at $108.54, the Chief Commercial Officer now owns 9,792 shares.
Before that, Hassanein Waleed H sold 56,000 shares. Transmedics Group Inc shares valued at $6,475,351 were divested by the President & CEO at a price of $115.63 per share. As a result of the transaction, Hassanein Waleed H now holds 74,087 shares, worth roughly $9.48 million.
Piper Sandler initiated its Transmedics Group Inc [TMDX] rating to an Overweight in a research note published on March 28, 2024; the price target was $95. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in mid July with a ‘”an Outperform”‘ rating. JP Morgan also remained covering TMDX and has increased its forecast on August 02, 2022 with a “an Overweight” recommendation from previously “Neutral” rating. JP Morgan revised its rating on October 08, 2020. It rated TMDX as “a Neutral” which previously was an “an Overweight”.
Price Performance Review of TMDX
On Friday, Transmedics Group Inc [NASDAQ:TMDX] saw its stock jump 2.85% to $127.99. Over the last five days, the stock has gained 39.00%. Transmedics Group Inc shares have risen nearly 62.16% since the year began. Nevertheless, the stocks have risen 75.28% over the past one year. While a 52-week high of $124.52 was reached on 05/03/24, a 52-week low of $36.42 was recorded on 03/25/24. SMA at 50 days reached $85.72, while 200 days put it at $73.06. A total of 1.54 million shares were traded, compared to the trading of 1.4 million shares in the previous session.
Levels Of Support And Resistance For TMDX Stock
The 24-hour chart illustrates a support level at 124.54, which if violated will result in even more drops to 121.09. On the upside, there is a resistance level at 130.55. A further resistance level may holdings at 133.11. The Relative Strength Index (RSI) on the 14-day chart is 80.43, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 26.11, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 3.57%. Stochastics %K at 93.44% indicates the stock is a selling.
The most recent change occurred on April 07, 2020 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $25 price target.
